info@seagull-health.com
SeagullHealth
语言:
search
new
Indications for Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
506
Article source: Seagull Pharmacy
Nov 06, 2025

Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is an innovative oral combination anti-diabetic formulation that integrates the dual advantages of a dipeptidyl peptidase-4 (DPP-4) inhibitor and a biguanide agent.

Indications for Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)

Primary Indication

Adjunctive treatment for type 2 diabetes in adults: Serving as an effective supplement to dietary control and exercise therapy, it is specifically indicated to improve blood glucose control in adult patients with type 2 diabetes.

Special Precautions

Contraindicated Populations: It must not be used for the treatment of patients with type 1 diabetes.

Risk of Pancreatitis: No systematic studies have been conducted in patients with a history of pancreatitis, so it cannot be determined whether the use of this drug in such patients will increase the risk of developing pancreatitis. A rigorous assessment of medication safety is necessary.

Dosage Strengths and Physical Characteristics of Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)

Sitagliptin 100 mg / Metformin Hydrochloride 1000 mg Extended-Release Tablets

Physical Appearance: Blue, biconvex, oval-shaped film-coated tablets.

Identification Marking: Imprinted with the code "81" on one side as an anti-counterfeiting mark.

Sitagliptin 50 mg / Metformin Hydrochloride 500 mg Extended-Release Tablets

Physical Appearance: Light blue, biconvex, oval-shaped film-coated tablets.

Identification Marking: Imprinted with the code "78" on one side.

Sitagliptin 50 mg / Metformin Hydrochloride 1000 mg Extended-Release Tablets

Physical Appearance: Light green, biconvex, oval-shaped film-coated tablets.

Identification Marking: Imprinted with the code "80" on one side.

Storage Instructions for Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)

Temperature Control Standards

Ideal Storage Temperature: 20°C to 25°C (68°F to 77°F).

Allowable Temperature Fluctuation Range: 15°C to 30°C (59°F to 86°F).

Storage Environment Requirements: Store in a dry area with the container tightly sealed.

Key Points for Packaging Management

Maintenance of Original Packaging: The original packaging must be retained, and the bottle cap must be kept tightly closed.

Child Safety Protection: Store the product in an area that is out of the reach of children.

Usage and Handling Specifications: Reseal the container immediately after each dose is taken.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
What Are the Side Effects of Tivozanib (Fotivda)?
Tivozanib (Fotivda) is a targeted therapy drug for recurrent or refractory advanced renal cell carcinoma, offering new hope to patients who have undergone multiple lines of systemic treatment. However...
Precautions for Administration of Tivozanib (Fotivda)
Tivozanib (Fotivda) is a kinase inhibitor. By targeting multiple tyrosine kinase targets such as vascular endothelial growth factor receptor (VEGFR), it inhibits tumor angiogenesis and is used for the...
How to Use Tivozanib (Fotivda)
Tivozanib (Fotivda) is a kinase inhibitor that was first approved in the United States in 2021. This medication is specifically indicated for the treatment of adult patients with advanced renal cell c...
Indications for Tivozanib Capsules (Fotivda)
Tivozanib Capsules (Fotivda) is a kinase inhibitor that was first approved in the United States in 2021. As an important drug for the treatment of advanced renal cell carcinoma, it blocks tumor angiog...
How to Use Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is a fixed-dose combination antihyperglycemic medication. It contains sitagliptin (a dipeptidyl peptidase-4 inhibitor) and met...
What Are the Side Effects of Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)?
Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is a fixed-dose combination preparation for the treatment of type 2 diabetes. It provides effective blood glucose control for ...
How to Purchase Enstilar
Enstilar is a prescription medication and must be obtained in strict compliance with medical regulatory procedures. It contains calcipotriene (a vitamin D analog) and betamethasone dipropionate (a cor...
Indications for Enstilar
Enstilar is an innovative topical fixed-dose combination preparation that integrates the dual effects of a vitamin D analog and a corticosteroid, specifically designed for the treatment of plaque psor...
Related Articles
Mercaptopurine Tablets: Side Effect Management and Storage Guidelines
Mercaptopurine is a chemotherapy drug used to treat acute lymphoblastic leukemia. Understanding its side effects, mastering relief methods, and proper storage are crucial for treatment safety.1. Commo...
Indications, contraindications, and use in special populations for Mercaptopurine Tablets
Mercaptopurine is a chemotherapy drug used to treat acute lymphoblastic leukemia. Clarifying its indications, contraindications, and key points for use in special populations is crucial for treatment ...
Major Side Effects of Cevimeline
Cevimeline is used to improve dry mouth caused by Sjögren's syndrome, but it may cause various side effects when used.I. Major Side Effects of Cevimeline1. Digestive System Side Effects(1) The mos...
Cevimeline: Indications, Contraindications, and Use in Special Populations
Cevimeline is a cholinergic agonist that primarily promotes salivation by stimulating M receptors in the salivary glands.I. Indications1. Core IndicationCevimeline is indicated only for the improvemen...
Indications of Infigratinib
Infigratinib is an oral kinase inhibitor targeting FGFR2, indicated for patients with specific gene mutations in cholangiocarcinoma.I. Indications1. Infigratinib is indicated for adult patients with p...
Common Side Effects of Infigratinib
Infigratinib has shown clear efficacy in the treatment of FGFR2-mutant cholangiocarcinoma, but may also cause various side effects.I. Common Side Effects1. Ocular Side Effects:(1) The most common ocul...
What is Momelotinib?
Momelotinib is an oral kinase inhibitor indicated for the treatment of adults with intermediate or high-risk myelofibrosis with anemia, including primary and secondary myelofibrosis.I. What is Momelot...
What are the common side effects of Momelotinib
Momelotinib is a targeted therapy used for the treatment of intermediate/high-risk myelofibrosis with anemia. Understanding its common side effects, mastering management strategies, and proper storage...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved